고바이오랩 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 신용원, was filed 20 Feb 2023.
고바이오랩: what insiders have been doing
고바이오랩 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). No insider at 고바이오랩 has published a filing in the past twelve months. The most recent one dates from 31 May 2024.
Over the whole record (from 2021), the tally stands at 1 purchase and 15 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ShareKRXDART:20240531002390
- 12,451 sharesKRXDART:20240531002373
- 16,000 sharesShareKRXDART:20230220000217Canonical exit: 2 May 2023 (T+90)
- ShareKRXDART:20221229000555
- ShareKRXDART:20220902000398
- ShareKRXDART:20220902000393
- 12,451 sharesKRXDART:20220831001535
- ShareKRXDART:20220707000555
- ShareKRXDART:20220707000553
- 12,451 sharesKRXDART:20220707000528
- ShareKRXDART:20211126000622
- ShareKRXDART:20211008000568
- 12,451 sharesKRXDART:20210906000323
- ShareKRXDART:20210413000130
- ShareKRXDART:20210413000150
- 12,451 sharesKRXDART:20210413000167
16 of 16 declarations
About 고바이오랩
고바이오랩 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for healthcare.
